Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Patients 20 & 21

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Jun 11, 2022 5:19am

150 Views

Post# 34748983

RE:RE:RE:RE:RE:RE:RE:RE:Patients 20 & 21

Anyone going to the AGM who likes to ask questions, feel free to ask if they can present their data so even regular folks can understand it. We should not have to guess what they mean. It is outright insulting to shareholders. Hopefully, they will make a good day out of the AGM

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages